Innovative Product Portfolio CannaboTech specializes in developing botanical-based remedies, creams, and supplements aimed at cancer patients and those undergoing chemotherapy, presenting opportunities to target oncology clinics, healthcare providers, and wellness centers seeking innovative natural therapies.

Digital Patient Engagement The launch of the free My Being App and real-time DNA monitoring indicates a focus on personalized medicine and patient engagement, opening avenues for partnerships with clinics and health platforms interested in integrated digital health solutions.

Strategic Collaborations Recent partnerships with NXTLVL for oncology product manufacturing in California suggest potential for expanding distribution channels and co-developing new formulations for international markets and specialized medical providers.

Research and Clinical Evidence CannaboTech's advanced research, including cell model studies showing significant cancer cell reduction, strengthens credibility and offers a compelling sales proposition to medical institutions emphasizing evidence-based integrative treatments.

Growth and Investment Potential Having recently gone public and experienced strategic acquisitions like Tikun Olam, CannaboTech presents an attractive opportunity for investors and distribution partners looking to capitalize on the growing medical cannabis and botanical medicine market.